PRODUCT LIABILITY | 2026-09-30

The Learned Intermediary Doctrine in California: Who a Drug Maker Must Warn

A manufacturer of a prescription drug or device generally satisfies its duty to warn by warning the prescribing physician — not the patient directly. Understanding this doctrine is central to any California pharmaceutical injury claim.

When a prescription drug or implanted device injures a patient, one of the first questions is whether the manufacturer failed to warn of the risk — and, crucially, <strong>whom</strong> the manufacturer was required to warn. In California, as in most states, the answer is governed by the <strong>lea

Prescription products are not sold like ordinary consumer goods; they reach the patient through a trained physician who weighs the risks and benefits. That reality drives a special warning rule.

The General Rule

Ordinarily, a product manufacturer must warn the end user of a product’s known or knowable dangers. But prescription drugs and devices are different: they are available only through a physician who exercises independent medical judgment. California recognizes the learned intermediary doctrine (confirmed by the California Supreme Court in Carlin v. Superior Court in the drug context), under which a manufacturer’s duty to warn runs to the prescribing physician rather than to the patient. If the manufacturer adequately warns the physician of the risks, it generally satisfies its duty — even if the patient never saw or understood the warning.

The Rationale

The doctrine rests on the physician’s role. The prescriber:

  • has the training to understand technical risk information;
  • knows the individual patient’s history and circumstances;
  • is positioned to weigh the drug’s risks against its benefits for that patient; and
  • can communicate the relevant risks to the patient in the course of obtaining informed consent.

Because the physician is the informed decision-maker, the law channels the manufacturer’s warning to the physician.

What an Adequate Physician Warning Requires

The doctrine protects the manufacturer only if the warning to the physician was adequate. A warning may be inadequate if it fails to disclose a known or reasonably knowable risk, understates the severity or frequency of a risk, or is buried or misleading. Whether a warning was adequate is generally a question of fact, informed by what the manufacturer knew or should have known at the relevant time. Importantly, California recognizes that a manufacturer’s duty extends to risks that were knowable in light of available scientific and medical knowledge — even a drug maker is not strictly liable for unknowable dangers, but it must warn of what the state of knowledge revealed.

Warning Causation

Even an inadequate warning does not create liability unless it caused the injury. In learned intermediary cases, causation typically focuses on the prescribing physician: would an adequate warning have changed the physician’s decision to prescribe, the manner of prescribing, or the information conveyed to the patient? If the physician already knew the risk, or would have prescribed the product regardless, the inadequate warning may not be a cause of the harm. This makes the prescriber’s testimony and knowledge central to the case.

Exceptions and Limits

The learned intermediary doctrine is not absolute. Recognized limits and potential exceptions include:

  • Direct-to-consumer marketing. Where a manufacturer markets a product directly to consumers, some authorities question whether warning only the physician should suffice — though California courts have generally continued to apply the doctrine.
  • Mass immunization and certain settings. Where a drug is dispensed without individualized physician involvement (for example, some vaccination programs), the rationale for the doctrine weakens.
  • Contraceptives and patient-directed products. Products where the patient makes an ongoing, active choice have prompted debate in some jurisdictions.

Whether an exception applies is fact-specific and legally contested, so the availability of an exception should be evaluated carefully.

Devices, Generics, and Federal Preemption

The doctrine applies to medical devices as well as drugs, but device and drug claims also implicate federal preemption — the extent to which FDA regulation displaces state-law claims (a complex area affecting, among others, branded versus generic drugs and premarket-approved devices). Preemption is a separate analysis layered on top of the learned intermediary framework, and both must be addressed in a prescription-product case.

Frequently Asked Questions

What is the learned intermediary doctrine?

The rule that a prescription drug or device maker generally satisfies its duty to warn by adequately warning the prescribing physician, rather than the patient directly.

What California case confirms it?

Carlin v. Superior Court, in which the California Supreme Court addressed failure-to-warn liability for prescription drugs within this framework.

Does the manufacturer ever have to warn the patient?

Generally not for prescription products, though exceptions have been discussed for direct-to-consumer marketing, mass immunization, and certain patient-directed products.

What makes a physician warning inadequate?

Failing to disclose a known or knowable risk, understating severity or frequency, or presenting the warning in a misleading or obscure way.

How is causation shown?

By showing an adequate warning would have changed the prescriber’s decision or the information given to the patient; if the physician already knew, causation may fail.

Does the doctrine apply to devices?

Yes — it applies to prescription devices as well, though federal preemption may separately limit device and drug claims.

Related Personal Injury Guides

Talk to a California Product Liability Attorney

If a prescription drug or device injured you, whether the manufacturer adequately warned your physician is a central question. Trembach Law Firm evaluates California pharmaceutical and device claims. Call (818) 514-7680.

Contact Trembach Law Firm at (818) 514-7680 for a confidential consultation.

Trembach Law Firm | 27001 Agoura Road, Suite 350, Calabasas, CA 91301